Influence of visceral obesity and liver fat on vascular structure and function in obese subjects

Obesity

Volumn 17, Issue 9, 2009, Pages 1783-1788

  Sturm, Wolfgang ^a   Sandhofer, Anton ^a   Engl, Julia ^a   Laimer, Markus ^a   Molnar, Clemens ^a   Kaser, Susanne ^a   Weiss, Helmut ^a   Tilg, Herbert ^a   Ebenbichler, Christoph F ^a   Patsch, Josef R ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD; BODY MASS; BRACHIAL ARTERY; CAROTID ARTERY; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FATTY LIVER; FEMALE; HOSPITALIZATION; HUMAN; INTIMA; INTRAABDOMINAL FAT; MALE; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TUNICA MEDIA; VASCULAR ENDOTHELIUM; VASODILATATION;

ADIPOSITY; ADULT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BODY MASS INDEX; BRACHIAL ARTERY; CAROTID ARTERIES; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FATTY LIVER; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; LINEAR MODELS; MALE; OBESITY; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TUNICA INTIMA; TUNICA MEDIA; VASODILATION;

EID: 69749104746     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.81     Document Type: Article

References (40)

1. Eckel RH, Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation 1998;97:2099-2100.
2. Peeters A, Barendregt JJ, Willekens F et al. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 2003;138:24-32.
3. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 1998;158:1855-1867.
4. Vigili de Kreutzenberg S, Kiwanuka E, Tiengo A, Avogaro A. Visceral obesity is characterized by impaired nitric oxide-independent vasodilation. Eur Heart J 2003;24:1210-1215.
5. Brook RD, Bard RL, Rubenfire M, Ridker PM, Rajagopalan S. Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults. Am J Cardiol 2001;88:1264-1269.
6. Lemieux I, Pascot A, Couillard C et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000;102:179-184.
7. Phillips ML, Boase S, Wahlroos S et al. Associates of change in liver fat content in the morbidly obese after laparoscopic gastric banding surgery. Diabetes Obes Metab 2008;10:661-667.
8. Brea A, Mosquera D, Martin E et al. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol 2005;25:1045-1050.
9. Chan SY, Mancini GB, Kuramoto L et al. The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. J Am Coll Cardiol 2003;42:1037-1043.
10. Fathi R, Haluska B, Isbel N, Short L, Marwick TH. The relative importance of vascular structure and function in predicting cardiovascular events. J Am Coll Cardiol 2004;43:616-623.
11. Arcaro G, Zamboni M, Rossi L et al. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes Relat Metab Disord 1999;23:936-942.
12. Ebenbichler C F, Laimer M, Kaser S et al. Relationship between cholesteryl ester transfer protein and atherogenic lipoprotein profile in morbidly obese women. Arterioscler Thromb Vasc Biol 2002;22:1465-1469.
13. Matthews DR, Hosker J P, Rudenski AS et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
14. Gaenzer H, Neumayr G, Marschang P et al. Effect of insulin therapy on endothelium-dependent dilation in type 2 diabetes mellitus. Am J Cardiol 2002;89:431-434.
15. Gaenzer H, Sturm W, Neumayr G et al. Pronounced postprandial lipemia impairs endothelium-dependent dilation of the brachial artery in men. Cardiovasc Res 2001;52:509-516.
16. Gaenzer H, Marschang P, Sturm W et al. Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J Am Coll Cardiol 2002;40:2189-2194.
17. Ebenbichler C F, Sturm W, Ganzer H et al. Flow-mediated, endothelium-dependent vasodilatation is impaired in male body builders taking anabolic-androgenic steroids. Atherosclerosis 2001;158:483-90.
18. Celermajer DS, Sorensen KE, Gooch VM et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-1115.
19. O?Leary DH, Polak JF, Kronmal RA et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14-22.
20. Luef GJ, Waldmann M, Sturm W et al. Valproate therapy and nonalcoholic fatty liver disease. Ann Neurol 2004;55:729-732.
21. Pontiroli AE, Pizzocri P, Giacomelli M et al. Ultrasound measurement of visceral and subcutaneous fat in morbidly obese patients before and after laparoscopic adjustable gastric banding: comparison with computerized tomography and with anthropometric measurements. Obes Surg 2002;12:648-651.
22. Dixon JB, Bhathal PS, Hughes NR, O?Brien PE. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 2004;39:1647-1654.
23. Targher G, Bertolini L, Padovani R et al. Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation. Diabetes Care 2004;27:2498-500.
24. Lakka TA, Lakka HM, Salonen R, Kaplan GA, Salonen JT. Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men. Atherosclerosis 2001;154:497-504. (Pubitemid 32146625)
25. De Michele M, Panico S, Iannuzzi A et al. Association of obesity and central fat distribution with carotid artery wall thickening in middle-aged women. Stroke 2002;33:2923-2928.
26. Despres J P. Health consequences of visceral obesity. Ann Med 2001;33:534-541.
27. Carr DB, Utzschneider KM, Hull RL et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004;53:2087-2094.
28. Stranges S, Dorn JM, Muti P et al. Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Hepatology 2004;39: 754-763.
29. Villanova N, Moscatiello S, Ramilli S et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005;42:473-480.
30. Laimer M, Ebenbichler C F, Kaser S et al. Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes Relat Metab Disord 2002;26:659-662.
31. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772-783.
32. Sandhofer A, Laimer M, Ebenbichler CF et al. Soluble leptin receptor and soluble receptor-bound fraction of leptin in the metabolic syndrome. Obes Res 2003;11:760-768.
33. Kaser S, Moschen A, Cayon A et al. Adiponectin and its receptors in nonalcoholic steatohepatitis. Gut 2005;54:117-121. (Pubitemid 40007229)
34. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004;24:29-33.
35. Tan KC, Xu A, Chow WS et al. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab 2004;89:765-769.
36. Ouchi N, Ohishi M, Kihara S et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 2003;42:231-234.
37. Musso G, Gambino R, Durazzo M et al. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology 2005;42:1175-1183.
38. Oh DK, Ciaraldi T, Henry RR. Adiponectin in health and disease. Diabetes Obes Metab 2007;9:282-289.
39. Beckman JA, Goldfine AB, Dunaif A, Gerhard-Herman M, Creager MA. Endothelial function varies according to insulin resistance disease type. Diabetes Care 2007.
40. Fernandez-Real JM, Castro A, Vazquez G et al. Adiponectin is associated with vascular function independent of insulin sensitivity. Diabetes Care 2004;27:739-745.